NASHVILLE, Tenn., Aug. 3, 2020 /PRNewswire/ -- Cryoport, Inc.
(NASDAQ: CYRX) ("Cryoport" or the "Company"), a global leader in
life sciences solutions, today announced that the Company will
report financial results for the second quarter ended June 30, 2020 on Thursday,
August 6, 2020 after U.S. markets close.
In addition to the earnings release, a document titled "Cryoport
Second Quarter 2020 in Review", providing a review of Cryoport's
recent financial and operational performance and a general business
update, will be issued at 4:05 pm ET on Thursday, August 6, 2020. The document is
designed to be read by investors before the questions and answers
conference call and can be accessed at
http://ir.cryoport.com/events-and-presentations.
Cryoport management will host a conference call at 5:00 pm ET on August 6,
2020. The conference call will be in the format of a
questions and answers session and will address any queries
investors have regarding the Company's reported results.
Conference Call Information
Date:
|
August 6,
2020
|
Time:
|
5:00 p.m.
ET
|
Dial-in
numbers:
|
+1 (800) 496-4125
(U.S.), +1 (720) 452-9104 (International)
|
Confirmation
code:
|
Request the "Cryoport
Call"
|
Live
webcast:
|
'Investor Relations'
section at www.cryoport.com or at this link. Please allow 10
minutes prior to the call to visit this site to download and
install any necessary audio software.
|
Questions and answers will be recorded and available
approximately three hours after completion of the live event on the
Investor Relations section of the Company's website at
www.cryoport.com for a limited time. To access the replay of
the questions and answers, please follow this link. A dial-in
replay of the call will also be available, to those interested,
until August 13, 2020. To access the
replay, dial +1 (844) 512-2921 (United
States) or +1 (412) 317-6671 (International) and enter
replay pin number: 7980251.
About Cryoport, Inc.
Cryoport, Inc. (Nasdaq: CYRX) is
redefining logistics for the life sciences industry by providing a
platform of temperature-controlled solutions, serving the
Biopharma, Reproductive Medicine, and Animal Health markets.
Our mission is to support life and health on earth by providing
reliable and comprehensive solutions for the life sciences industry
through our advanced technologies, Global Supply Chain Network and
dedicated scientists, technicians and supporting team of
professionals. Through its purpose-built, proprietary Cryoport
Express® Shippers; Cryoportal® information technology; validated
Global Logistics Centers; smart and sustainable
temperature-controlled logistics; and biostorage/biobanking
services, Cryoport serves clients in life sciences research,
clinical trials, and product commercialization. We support
life-saving advanced cell and gene therapies and deliver vaccines,
protein producing materials, and IVF materials in over 100
countries around the world. For more information, visit
www.cryoport.com or follow @cryoport on Twitter at
www.twitter.com/cryoport for live updates.
Forward-Looking Statements
Statements in
this news release which are not purely historical, including
statements regarding Cryoport's intentions, hopes, beliefs,
expectations, representations, projections, plans or predictions of
the future are forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995. It is important
to note that Cryoport's actual results could differ materially from
those in any such forward-looking statements. Factors that could
cause actual results to differ materially include, but are not
limited to, risks and uncertainties associated with the effect of
changing economic conditions, trends in the products markets,
variations in Cryoport's cash flow, market acceptance risks, and
technical development risks. Cryoport's business could be affected
by a number of other factors, including the risk factors listed
from time to time in Cryoport's SEC reports including, but not
limited to, Cryoport's 10-K for the year ended December 31, 2019, Cryoport's Quarterly Report on
Form 10-Q for the quarter ended March 31,
2020 and any subsequent filings with the SEC. Cryoport
cautions investors not to place undue reliance on the
forward-looking statements contained in this press release, which
speak only as of the date of this press release. Except as required
by law, Cryoport disclaims any obligation, and does not undertake,
to update or revise any forward-looking statements in this press
release.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cryoport-to-report-second-quarter-2020-financial-results-on-august-6-2020-301104958.html
SOURCE Cryoport, Inc.